Search

everythinglearnresearchcommunity

for

Search:↓

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Panax notoginseng saponins with stem cells improve healing and reduce inflammation in diabetic ulcers.

New cytokine-targeted therapies show promise for treating alopecia areata.

The gel effectively delivers drugs to the eye, fights bacteria, and protects against oxidative stress.

Ocrelizumab may cause total body hair loss in some patients.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tofacitinib may help treat hair loss in children with alopecia areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

New psoriasis treatments are effective but come with side effects and risks.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.